SCHEMBL2025903

SCHEMBL2025903

COc1ccc(CCc2cnc(N)c3nnc(N)n23)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
ATM Q13315 2/20 0.43
KDM4E B2RXH2 1/20 0.43
DHFR P00374 1/20 0.43
HTT P42858 1/20 0.43
FYN P06241 1/20 0.40
AOC3 Q16853 1/20 0.40
ABCB1 P08183 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2025901 0.71 CYP19A1 (0.48) CYP19A1ATMKDM4EDHFRHTT
SCHEMBL16641094 0.69 CYP19A1 (0.77) CYP19A1ATMKDM4EAOC3ABCB1
SCHEMBL31157848 0.69 CYP19A1 (0.77) CYP19A1ATMKDM4EAOC3ABCB1
SCHEMBL10335393 0.67 CYP19A1 (0.81) CYP19A1ATMKDM4EAOC3ABCB1
SCHEMBL6481605 0.67 CYP19A1 (1.00) CYP19A1ATMKDM4EAOC3KMT2A
SCHEMBL2019846 0.65 ALDH1A1 (0.48) CYP19A1ATMKDM4EDHFRHTT
SCHEMBL14427584 0.64 ALDH1A1 (0.76) CYP19A1ATMKDM4EAOC3ALDH1A1
SCHEMBL29351641 0.63 ATM (1.00) CYP19A1ATMKDM4EAOC3MEN1
SCHEMBL6891346 0.63 ATM (0.66) CYP19A1ATMKDM4EAOC3ALDH1A1
SCHEMBL210639 0.63 ATM (1.00) CYP19A1ATMKDM4EAOC3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329705-B2 Substituted triazolo-pyrazine compounds ARQULE, INC. (US) 2012-12-11 US disclosed
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds ARQULE, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds MKI67, TP53, THPO CYP19A1 493/4885ATM 977/4885KDM4E 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.